Genmab A (GMAB) Net Debt Issuances and Repayments (2024 - 2025)
Genmab A (GMAB) posted Net Debt Issuances and Repayments of $72.0 million for Q1 2025, up 101.84% on a QoQ basis from -$3.9 billion in Q3 2024, and up 184.71% year-over-year from $25.3 million in Q1 2024.
Genmab A (GMAB) Net Debt Issuances and Repayments (2024 - 2025) Analysis & Trends
Genmab A's Net Debt Issuances and Repayments history runs 2 years deep, the most recent figure standing at $72.0 million for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | - |
| 10 | Genmab A | 1.88 Bn | 354.62 Mn | 831.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 72.00 Mn |
| Mar 31, 2025 | 72.00 Mn |
| Sep 30, 2024 | -3.92 Bn |
| Sep 30, 2024 | -3.92 Bn |
| Mar 31, 2024 | -85.00 Mn |
| Mar 31, 2024 | -85.00 Mn |